These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 10187877)
1. Association of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator. Manelfe C; Larrue V; von Kummer R; Bozzao L; Ringleb P; Bastianello S; Iweins F; Lesaffre E Stroke; 1999 Apr; 30(4):769-72. PubMed ID: 10187877 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy. Tomsick T; Brott T; Barsan W; Broderick J; Haley EC; Spilker J; Khoury J AJNR Am J Neuroradiol; 1996 Jan; 17(1):79-85. PubMed ID: 8770253 [TBL] [Abstract][Full Text] [Related]
3. Acute stroke with hyperdense middle cerebral artery sign benefits from IV rtPA. Tartaglia MC; Di Legge S; Saposnik G; Jain V; Chan R; Bussière M; Hachinski V; Frank C; Hesser K; Pelz D Can J Neurol Sci; 2008 Nov; 35(5):583-7. PubMed ID: 19235441 [TBL] [Abstract][Full Text] [Related]
4. Persistence of hyperdense middle cerebral artery sign on follow-up CT scan after intravenous thrombolysis is associated with poor outcome. Paliwal PR; Ahmad A; Shen L; Yeo LL; Loh PK; Ng KW; Chong VF; Ong BK; Venketasubramanian N; Sinha AK; Teoh HL; Bathla G; Chan BP; Sharma VK Cerebrovasc Dis; 2012; 33(5):446-52. PubMed ID: 22456065 [TBL] [Abstract][Full Text] [Related]
5. Hyperdense middle cerebral artery sign: can it be used to select intra-arterial versus intravenous thrombolysis in acute ischemic stroke? Agarwal P; Kumar S; Hariharan S; Eshkar N; Verro P; Cohen B; Sen S Cerebrovasc Dis; 2004; 17(2-3):182-90. PubMed ID: 14707420 [TBL] [Abstract][Full Text] [Related]
6. Hyperdense middle cerebral artery sign on admission CT scan--prognostic significance for ischaemic stroke patients treated with intravenous thrombolysis in the safe implementation of thrombolysis in Stroke International Stroke Thrombolysis Register. Kharitonova T; Ahmed N; Thorén M; Wardlaw JM; von Kummer R; Glahn J; Wahlgren N Cerebrovasc Dis; 2009; 27(1):51-9. PubMed ID: 19018138 [TBL] [Abstract][Full Text] [Related]
7. Hyperdense middle cerebral artery sign and outcome after intravenous thrombolysis for acute ischemic stroke. Aries MJ; Uyttenboogaart M; Koopman K; Rödiger LA; Vroomen PC; De Keyser J; Luijckx GJ J Neurol Sci; 2009 Oct; 285(1-2):114-7. PubMed ID: 19576595 [TBL] [Abstract][Full Text] [Related]
8. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451 [TBL] [Abstract][Full Text] [Related]
9. Proximal hyperdense middle cerebral artery sign predicts poor response to thrombolysis. Li Q; Davis S; Mitchell P; Dowling R; Yan B PLoS One; 2014; 9(5):e96123. PubMed ID: 24804962 [TBL] [Abstract][Full Text] [Related]
10. Hyperdense middle cerebral artery sign is associated with increased risk of hemorrhagic transformation after intravenous thrombolysis for patients with acute ischaemic stroke. Zou M; Churilov L; He A; Campbell B; Davis SM; Yan B J Clin Neurosci; 2013 Jul; 20(7):984-7. PubMed ID: 23664409 [TBL] [Abstract][Full Text] [Related]
11. Intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign: A meta-analysis. Sun H; Liu Y; Gong P; Zhang S; Zhou F; Zhou J Acta Neurol Scand; 2020 Mar; 141(3):193-201. PubMed ID: 31598961 [TBL] [Abstract][Full Text] [Related]
12. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. del Zoppo GJ; Higashida RT; Furlan AJ; Pessin MS; Rowley HA; Gent M Stroke; 1998 Jan; 29(1):4-11. PubMed ID: 9445320 [TBL] [Abstract][Full Text] [Related]
13. Disappearing hyperdense middle cerebral artery sign is associated with striatocapsular infarcts on follow-up CT in ischemic stroke patients treated with intravenous thrombolysis. van Overbeek EC; Knottnerus IL; van Oostenbrugge RJ Cerebrovasc Dis; 2010 Aug; 30(3):285-9. PubMed ID: 20664262 [TBL] [Abstract][Full Text] [Related]
14. Comparison of intraarterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign. Mattle HP; Arnold M; Georgiadis D; Baumann C; Nedeltchev K; Benninger D; Remonda L; von Büdingen C; Diana A; Pangalu A; Schroth G; Baumgartner RW Stroke; 2008 Feb; 39(2):379-83. PubMed ID: 18096842 [TBL] [Abstract][Full Text] [Related]
15. [Hyperdense middle cerebral artery sign among patients with severe ischemic attack on ultra-early phase]. Song HS; Yuan HS; Fan DS Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Feb; 44(1):142-6. PubMed ID: 22353918 [TBL] [Abstract][Full Text] [Related]
16. Disappearance of the hyperdense MCA sign after stroke thrombolysis: implications for prognosis and early patient selection for clot retrieval. Elofuke P; Reid JM; Rana A; Macleod MJ J R Coll Physicians Edinb; 2016 Jun; 46(2):81-86. PubMed ID: 27929569 [TBL] [Abstract][Full Text] [Related]
17. Disappearing hyperdense middle cerebral artery sign in ischaemic stroke patients treated with intravenous thrombolysis: clinical course and prognostic significance. Kharitonova T; Thorén M; Ahmed N; Wardlaw JM; von Kummer R; Thomassen L; Wahlgren N; J Neurol Neurosurg Psychiatry; 2009 Mar; 80(3):273-8. PubMed ID: 18931005 [TBL] [Abstract][Full Text] [Related]
18. The Hyperdense Middle Cerebral Artery Sign in Drip-and-Ship Models of Acute Stroke Management. Jodaitis L; Ligot N; Chapusette R; Bonnet T; Gaspard N; Naeije G Cerebrovasc Dis Extra; 2020; 10(1):36-43. PubMed ID: 32344421 [TBL] [Abstract][Full Text] [Related]
20. [Efficacy of intravenous thrombolysis in acute ischemic stroke with hyperdense middle cerebral artery sign]. Peng L; Guo Y; Wang Y; Lin YN; Zhang CH; Wang HY; Yu RM; Sun XP Zhonghua Yi Xue Za Zhi; 2017 Jan; 97(3):193-197. PubMed ID: 28162169 [No Abstract] [Full Text] [Related] [Next] [New Search]